Loading
Archives of Autoimmune Diseases
ISSN: 2767-3340
Zyxell Inc
USA
Academic Editor
Yongxin Zhang, CEO and president of Zyxell Inc., graduated from Beijing Medical University (Beijing, China) for his MD in 1983 and Ph.D. in 1989, and completed his postdoctoral training in Baylor College of Medicine (Houston, USA) in 2004 for molecular virology and immunology. His studies include pathogenesis, diagnosis, prevention and treatment of infectious diseases and cancer, transplantation immunology, vaccines and immunoassays. He worked as a physician for more than 10 years for infectious diseases and cancer in china. After he came to US in 1996, he worked as a postdoctoral research fellow in Baylor college of medicine, Research scientist in Methrogen Inc., senior scientist and director of research in Regenetech Inc, and CEO in Zyxell Inc. for totally over 25 years.
His research areas include Immunology, Microbiology, Epidemiology, cell transplantation, stem cell technology, and bioreactor development, vaccine development, infectious diseases, cancer Biology, autoimmune diseases, liver pathology and immunoassay development.